InSilixa is seeking a highly motivated senior scientist to lead a variety of R&D projects relevant for its CMOS-based molecular diagnostic (MDx) platform. The primary responsibilities include development of a novel nucleic acid amplification...
Zephyrus Biosciences is commercializing transformative single-cell protein analysis technology that can unlock heterogeneity in cell populations. Our first product, the scWestern system, enables western blotting on individual cells for the first...
We are seeking a highly motivated & enthusiastic Associate Scientist to join the in vitro biology group at Nektar to contribute to the development of cell-based functional assays, particularly in the areas of immunology and inflammation for our...
EnCorps Teachers Program
If you have ever considered becoming a math, science, engineering or technology teacher, join our prestigious Corps of Educators inspiring tomorrow's innovators!
The EnCorps STEM Teachers Program (www.encorps.org) is a nonprofit organization that...
OncoMed Pharmaceuticals, Inc.
The Cancer Biology Department is seeking a highly motivated, hard-working and reliable intern at the Ph.D. level to join the research team. The successful candidate will play an important role in existing oncology drug discovery...
NIH/NCI - National Cancer Institute
Department of Health and Human Services
National Institutes of Health
National Cancer Institute
Division of Cancer Control and Population Sciences
Associate Director, Healthcare Delivery Research Program
The National Cancer Institute (NCI), the...
Lifecode is a specialized clinical laboratory focused on the genetic basis of human disease. With an initial focus on oncology, we are committed to improving the lives of patients through molecular information that is concise, accurate and...
Compugen USA, Inc.
South San Francisco,
COMPANY: Compugen USA, Inc., a wholly owned subsidiary of Compugen Ltd., develops therapeutic antibodies for the treatment of cancer. Working closely with colleagues in Tel Aviv, we are advancing multiple programs targeting novel immune checkpoint...